These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32332313)

  • 1. Renal Medullary Carcinoma on Dual-Time Point FDG PET/CT Imaging.
    Hou G; Jiang Y; Wang J; Li F; Cheng W
    Clin Nucl Med; 2020 Jun; 45(6):446-447. PubMed ID: 32332313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG PET/CT of Chromophobe Renal Cell Carcinoma With Sarcomatoid Differentiation.
    Lee CH; Kesari V; Legesse T; Chen W
    Clin Nucl Med; 2018 May; 43(5):367-369. PubMed ID: 29485439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal medullary carcinoma in a young mixed-race man in Japan.
    Toriyama A; Izumi H; Tomita S; Nagashima Y; Ueda Y; Aoki Y; Tsujimura A; Yao T; Hino O
    Pathol Int; 2019 Apr; 69(4):241-245. PubMed ID: 30843648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a renal medullary carcinoma in an adolescent male with sickle cell trait by Tc-99m methylene disphosponate bone scintigraphy.
    Brown JM; Berkey BD; Brooks JA
    Clin Nucl Med; 2008 Dec; 33(12):896-900. PubMed ID: 19033803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of renal medullary carcinoma in children and young adults: a report from the Children's Oncology Group.
    Sandberg JK; Mullen EA; Cajaiba MM; Smith EA; Servaes S; Perlman EJ; Geller JI; Ehrlich PF; Cost NG; Dome JS; Fernandez CV; Khanna G
    Pediatr Radiol; 2017 Nov; 47(12):1615-1621. PubMed ID: 28689245
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Souteiro P; Gouveia P; Ferreira G; Belo S; Costa C; Carvalho D; Duarte H; Sampaio IL
    Endocrine; 2019 May; 64(2):322-329. PubMed ID: 30684230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging.
    Marzola MC; Pelizzo MR; Ferdeghini M; Toniato A; Massaro A; Ambrosini V; Fanti S; Gross MD; Al-Nahhas A; Rubello D
    Eur J Surg Oncol; 2010 Apr; 36(4):414-21. PubMed ID: 20100647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma.
    Karivedu V; Jain AL; Eluvathingal TJ; Sidana A
    Curr Urol Rep; 2019 Aug; 20(10):56. PubMed ID: 31468240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Medullary Carcinoma Associated with Sickle Cell Trait.
    Frazier AA
    Radiographics; 2017; 37(5):1537. PubMed ID: 28898179
    [No Abstract]   [Full Text] [Related]  

  • 10. Fine needle aspiration cytology diagnosis of renal medullary carcinoma: a case report.
    Qi J; Shen PU; Rezuke WN; Currier AA; Westfall PK; Mandavilli SR
    Acta Cytol; 2001; 45(5):735-9. PubMed ID: 11575652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT in a patient affected by renal collecting duct (Bellini) carcinoma.
    Bertagna F; Fisogni S; Tardanico R; Simeone C; Cunico SC; Giubbini R
    Clin Nucl Med; 2012 Oct; 37(10):986-8. PubMed ID: 22955073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ¹⁸F-FDG-PET and ¹⁸F-FDG-PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: a systematic review and meta-analysis.
    Cheng X; Bao L; Xu Z; Li D; Wang J; Li Y
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):136-42. PubMed ID: 22498184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of
    Nakamoto Y; Ishimori T; Shimizu Y; Sano K; Togashi K
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1524-1530. PubMed ID: 30847538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using
    Nakajima R; Nozaki S; Kondo T; Nagashima Y; Abe K; Sakai S
    Eur Radiol; 2017 Nov; 27(11):4866-4873. PubMed ID: 28523353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of renal cell carcinoma in patients with acquired cystic disease of the kidney: comparison
    Kitajima K; Yamamoto S; Kawanaka Y; Katsuura T; Fujita M; Nakanishi Y; Yamada Y; Hashimoto T; Suzuki T; Go S; Kanematsu A; Nojima M; Yamakado K
    Jpn J Radiol; 2019 Feb; 37(2):165-177. PubMed ID: 30377936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography (18FDG-PET) in the detection of medullary thyroid carcinoma metastases.
    Mucha SA; Kunert-Radek J; Pomorski L
    Endokrynol Pol; 2006; 57(4):452-5. PubMed ID: 17006852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal medullary carcinoma metastatic to the orbit: a clinicopathologic report.
    Zdinak LA; Nik NA; Hidayat AA; Hargett NA
    Ophthalmic Plast Reconstr Surg; 2004 Jul; 20(4):322-5. PubMed ID: 15266151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Medullary Carcinoma With Metastasis to the Temporal Fossa and Orbit.
    Chumdermpadetsuk R; Tooley AA; Godfrey KJ; Krawitz B; Feldstein N; Kazim M
    Ophthalmic Plast Reconstr Surg; 2019; 35(6):e149-e151. PubMed ID: 31574041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased FDG Uptake on Juxtaglomerular Cell Tumor in the Left Kidney Mimicking Malignancy.
    Jiang Y; Hou G; Zhu Z; Zang J; Cheng W
    Clin Nucl Med; 2020 Mar; 45(3):252-254. PubMed ID: 31977483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced MRI and 18F-FDG PET/CT Findings of Preoperative Primary Renal Collecting Duct Carcinoma.
    Ge J; Zuo C; Guan Y; Liang Z
    Clin Nucl Med; 2016 Dec; 41(12):998-999. PubMed ID: 27775947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.